David C. Marek - Jan 19, 2022 Form 4 Insider Report for Myovant Sciences Ltd. (MYOV)

Role
Principal Executive Officer, Director
Signature
/s/ Matthew Lang, Attorney-in-fact
Stock symbol
MYOV
Transactions as of
Jan 19, 2022
Transactions value $
-$291,868
Form type
4
Date filed
1/21/2022, 03:08 PM
Next filing
Apr 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Sale -$292K -19.9K -5.56% $14.68 338K Jan 19, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.